Marks Group Wealth Management Inc lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,191 shares of the medical equipment provider’s stock after selling 147 shares during the period. Marks Group Wealth Management Inc’s holdings in Intuitive Surgical were worth $5,498,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Norden Group LLC lifted its position in Intuitive Surgical by 32.4% during the first quarter. Norden Group LLC now owns 957 shares of the medical equipment provider’s stock worth $382,000 after purchasing an additional 234 shares during the period. Richardson Financial Services Inc. bought a new position in Intuitive Surgical in the first quarter valued at approximately $46,000. Csenge Advisory Group raised its position in Intuitive Surgical by 16.4% during the first quarter. Csenge Advisory Group now owns 1,229 shares of the medical equipment provider’s stock valued at $490,000 after purchasing an additional 173 shares in the last quarter. Geneva Capital Management LLC lifted its stake in Intuitive Surgical by 20.3% during the first quarter. Geneva Capital Management LLC now owns 5,390 shares of the medical equipment provider’s stock worth $2,151,000 after purchasing an additional 911 shares during the last quarter. Finally, Advisory Alpha LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter valued at $414,000. 83.64% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities analysts have recently commented on ISRG shares. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley raised their price target on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Raymond James upped their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Finally, The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $513.74.
Intuitive Surgical Stock Up 1.5 %
ISRG stock opened at $515.17 on Wednesday. The company’s fifty day simple moving average is $491.63 and its 200 day simple moving average is $449.59. Intuitive Surgical, Inc. has a 12-month low of $269.49 and a 12-month high of $523.34. The firm has a market cap of $183.49 billion, a price-to-earnings ratio of 82.82, a PEG ratio of 4.98 and a beta of 1.39.
Insider Activity
In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 240 shares of the stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 68,246 shares of company stock valued at $33,839,308 in the last ninety days. 0.80% of the stock is owned by company insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Where to Find Earnings Call Transcripts
- AMD: The AI Disruptor – Is It Time to Follow Big Tech’s Lead?
- Profitably Trade Stocks at 52-Week Highs
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Bears Misjudged These 3 ETFs: Where Investors Can Find Upside
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.